"10.1371_journal.pone.0138248","plos one","2015-09-17T00:00:00Z","Adil Doganay Duru; Tolga Sutlu; Ann Wallblom; Katarina Uttervall; Johan Lund; Birgitta Stellan; Gösta Gahrton; Hareth Nahi; Evren Alici","Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden; Center for Diseases of Aging, Vaccine and Gene Therapy Institute of Florida, Port St. Lucie, Florida, United States of America; Nanotechnology Research and Application Center, Sabanci University, Istanbul, Turkey; Haematology Centre, Karolinska University Hospital, Huddinge, Stockholm, Sweden","Conceived and designed the experiments: ADD TS GG EA HN. Performed the experiments: ADD TS AW BS. Analyzed the data: ADD TS HN KU JL. Contributed reagents/materials/analysis tools: HN KU JL. Wrote the paper: ADD TS GG EA HN.","Authors except GG declare no conflicts of interest. GG is an “advisor” to Fujimoto Pharmaceutical Company, Japan and has received financial support from the Celgene Company, USA. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.",NA,NA,NA,"2015","09","Adil Doganay Duru","ADD",9,TRUE,5,4,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
